Clinical trial
Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug…
NCT00158834 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00158834 |
|---|---|
| Title | Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma Medications |
| Official title | Comparison of Stepwise Treatment of Asthmatic Children With Salmeterol/Fluticasone Propionate Combination Product (Seretide®) and/or Fluticasone Propionate (Flixotide®) Based on PD20 Methacholine and Symptoms or Based on Symptoms Only (Children Asthma Therapy Optimal) |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Salmeterol/Fluticasone propionate combination product, Fluticasone propionate |
| Enrollment | 200 |
| Start date | Nov 1, 1999 |
| First posted | Sep 12, 2005 |
| Last update posted | Oct 13, 2008 |
| Countries | Netherlands |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: